About 48,000 doses were delivered in the seven days to midnight on April 20.
New model released by health ministry picks up where DHB plan leaves off and shows plan for eight million doses to be delivered by the end of the year.
Pacific Edge's tests for diagnosing and monitoring bladder cancer now have approvals from a number of major US healthcare administrators.
The pharmaceuticals company has also appointed Lorraine Corr-Poppleton as its Hong Kong-based Asia business manager.